Longitude Capital Partners III, LLC
Related Filers (13)
- Longitude Venture Partners III, L.P. (22)
- ENRIGHT PATRICK G (22)
- Tammenoms Bakker Juliet (20)
- Molecular Templates, Inc. (12)
- Sierra Oncology, Inc. (10)
- 89bio, Inc. (9)
- Inozyme Pharma, Inc. (6)
- Axonics Modulation Technologies, Inc. (5)
- Tourmaline Bio, Inc. (4)
- Strongbridge Biopharma plc (2)
- Longitude Prime Partners, LLC (2)
- Longitude Prime Fund, L.P. (2)
- Checkmate Pharmaceuticals, Inc. (1)
- Show More ...
Ownership (49)
SC 13D/A
Monday, 10/30/2023
Tourmaline Bio, Inc.: Major Shareholders
SC 13D/A
Tuesday, 10/24/2023
Molecular Templates, Inc.: Major Shareholders
SC 13D/A
Friday, 8/11/2023
Inozyme Pharma, Inc.: Major Shareholders
SC 13D/A
Tuesday, 2/14/2023
89bio, Inc.: Major Shareholders
SC 13D/A
Tuesday, 2/14/2023
Molecular Templates, Inc.: Major Shareholders
SC 13D/A
Friday, 5/6/2022
Sierra Oncology, Inc.: Major Shareholders
4
Friday, 4/29/2022
Sierra Oncology, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 4/28/2022
Inozyme Pharma, Inc.: Major Shareholders
4
Thursday, 4/21/2022
Inozyme Pharma, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 2/7/2022
89bio, Inc.: Major Shareholders
SC 13D/A
Friday, 2/4/2022
Sierra Oncology, Inc.: Major Shareholders
4
Wednesday, 2/2/2022
Sierra Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/27/2022
Sierra Oncology, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 11/8/2021
Sierra Oncology, Inc.: Major Shareholders
SC 13D
Friday, 5/21/2021
Talaris Therapeutics, Inc.: Major Shareholders
4
Tuesday, 5/11/2021
Talaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 5/6/2021
Talaris Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Tuesday, 1/26/2021
Axonics Modulation Technologies, Inc.: Major Shareholders
SC 13D/A
Wednesday, 11/25/2020
89bio, Inc.: Major Shareholders
4
Wednesday, 11/18/2020
89bio, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/1/2020
Molecular Templates, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Friday, 8/21/2020
Checkmate Pharmaceuticals, Inc.: Major Shareholders
SC 13D/A
Thursday, 8/20/2020
Axonics Modulation Technologies, Inc.: Major Shareholders
SC 13D
Friday, 8/7/2020
Inozyme Pharma, Inc.: Major Shareholders
4
Tuesday, 7/28/2020
Inozyme Pharma, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/23/2020
Inozyme Pharma, Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Monday, 7/20/2020
89bio, Inc.: Major Shareholders
4
Tuesday, 7/14/2020
89bio, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 6/5/2020
Molecular Templates, Inc.: Major Shareholders
4
Thursday, 5/28/2020
Molecular Templates, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 2/10/2020
Sierra Oncology, Inc.: Major Shareholders
4
Friday, 1/31/2020
Sierra Oncology, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 12/5/2019
Molecular Templates, Inc.: Major Shareholders
4/A
Thursday, 12/5/2019
Molecular Templates, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/27/2019
Molecular Templates, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 11/26/2019
Sierra Oncology, Inc.: Initial statement of beneficial ownership of securities
SC 13D
Monday, 11/25/2019
Sierra Oncology, Inc.: Major Shareholders
SC 13D
Thursday, 11/21/2019
89bio, Inc.: Major Shareholders
4
Wednesday, 11/13/2019
89bio, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 11/8/2019
89bio, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Tuesday, 2/12/2019
Strongbridge Biopharma plc: Major Shareholders
SC 13D
Friday, 11/9/2018
Axonics Modulation Technologies, Inc.: Major Shareholders
SC 13G
Friday, 11/9/2018
Strongbridge Biopharma plc: Major Shareholders
4
Friday, 11/2/2018
Axonics Modulation Technologies, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 10/30/2018
Axonics Modulation Technologies, Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Wednesday, 9/26/2018
Molecular Templates, Inc.: Major Shareholders
4
Tuesday, 9/25/2018
Molecular Templates, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Monday, 9/18/2017
Molecular Templates, Inc.: Major Shareholders
3
Monday, 8/7/2017
Molecular Templates, Inc.: Initial statement of beneficial ownership of securities